D1000 Varejo Farma Participacoes (BSP:DMVF3) Current Deferred Revenue: R$0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:DMVF3 D1000 Varejo Farma Participacoes SA BSP:DMVF3
79 GF Score
Price R$6.39
GF Value R$8.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is D1000 Varejo Farma Participacoes Current Deferred Revenue?

D1000 Varejo Farma Participacoes BSP:DMVF3 -0.31% 79 Current Deferred Revenue is R$0 Mil as of Mar. 2026. GuruFocus rates BSP:DMVF3 with a GF Score™ of 79/100 and a GF Value™ of R$8.14 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

D1000 Varejo Farma Participacoes's current deferred revenue for the quarter that ended in Mar. 2026 was R$0 Mil.

D1000 Varejo Farma Participacoes Current Deferred Revenue Related Terms

D1000 Varejo Farma Participacoes Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for D1000 Varejo Farma Participacoes's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

D1000 Varejo Farma Participacoes Current Deferred Revenue Chart

D1000 Varejo Farma Participacoes Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

D1000 Varejo Farma Participacoes Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BSP:DMVF3
79GF Score
D1000 Varejo Farma Participacoes SA BSP:DMVF3
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of R$0 Mil mean?
D1000 Varejo Farma Participacoes (BSP:DMVF3) has a Current Deferred Revenue of R$0 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on D1000 Varejo Farma Participacoes and its competitors.
Is D1000 Varejo Farma Participacoes' Current Deferred Revenue too high?
D1000 Varejo Farma Participacoes' current Current Deferred Revenue is R$0 Mil. Overall, D1000 Varejo Farma Participacoes has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does D1000 Varejo Farma Participacoes' Current Deferred Revenue compare to competitors?
D1000 Varejo Farma Participacoes' Current Deferred Revenue of R$0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on D1000 Varejo Farma Participacoes and its competitors. D1000 Varejo Farma Participacoes's current Current Deferred Revenue is R$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D1000 Varejo Farma Participacoes stock overvalued right now?
Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes (BSP:DMVF3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.14, compared to a current price of R$6.39 — trading 21.5% below its estimated fair value. The current Current Deferred Revenue is R$0 Mil. D1000 Varejo Farma Participacoes' overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For D1000 Varejo Farma Participacoes (BSP:DMVF3), the current Current Deferred Revenue is R$0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is D1000 Varejo Farma Participacoes (BSP:DMVF3) Overvalued in 2026?

Based on GuruFocus' analysis, D1000 Varejo Farma Participacoes stock appears to be undervalued. The current stock price of R$6.39 is trading 21.5% below its estimated GF Value™ of R$8.14. GuruFocus considers D1000 Varejo Farma Participacoes to be Modestly Undervalued.

Key valuation signals for BSP:DMVF3:

  • Current Deferred Revenue: R$0 Mil
  • GF Value™: R$8.14 vs. price of R$6.39 (21.5% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the BSP:DMVF3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

D1000 Varejo Farma Participacoes Business Description

Address Cidade de Deus. Predio Amarelo, 2nd Floor, Osasco, SP, BRA, 6029900
D1000 Varejo Farma Participacoes SA invests in national or foreign pharmaceutical retail companies.
79GF Score

Get the complete analysis for BSP:DMVF3

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.39
Price
R$8.14
GF Value